|
TSNAX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.81437153768638E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6295853555448E-12 |
| Normal-vs-Stage2 |
1.71589999986566E-07 |
| Normal-vs-Stage3 |
4.647900E-04 |
| Normal-vs-Stage4 |
1.032670E-04 |
| Stage1-vs-Stage2 |
3.918600E-01 |
| Stage1-vs-Stage3 |
9.720500E-03 |
| Stage1-vs-Stage4 |
3.346200E-01 |
| Stage2-vs-Stage3 |
2.673400E-01 |
| Stage2-vs-Stage4 |
7.759400E-01 |
| Stage3-vs-Stage4 |
5.537400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.90878432451791E-14 |
| Normal-vs-AfricanAmerican |
1.38929978632518E-10 |
| Normal-vs-Asian |
6.43029999999323E-05 |
| Caucasian-vs-AfricanAmerican |
3.863600E-01 |
| Caucasian-vs-Asian |
9.003000E-01 |
| AfricanAmerican-vs-Asian |
7.009800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
3.34140000113337E-08 |
| Male-vs-Female |
5.034200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.34840000007597E-07 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
5.06520381193809E-11 |
| Normal-vs-Extreme_Obese |
4.463000E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.208400E-02 |
| Normal_Weight-vs-Obese |
6.998400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.535800E-01 |
| Extreme_Weight-vs-Obese |
1.475720E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.146400E-01 |
| Obese-vs-Extreme_Obese |
8.796600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.70718999999986E-05 |
| Normal-vs-Age(41-60Yrs) |
1.99540384215879E-12 |
| Normal-vs-Age(61-80Yrs) |
1.27675647831893E-14 |
| Normal-vs-Age(81-100Yrs) |
8.36190006126003E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.453000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.242000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.923800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.452600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.471200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.966000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
3.23600000129431E-08 |
| Normal-VS-KIRP CIMP |
3.024600E-04 |
| Normal-VS-Unclassified PRCC |
2.97250002390115E-09 |
| Type1 PRCC-VS-Type2 PRCC |
5.661800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.106500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.519500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.199800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.697600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.431800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74582611992491E-12 |
| Normal-vs-N1 |
3.758800E-03 |
| Normal-vs-N2 |
4.762700E-04 |
| N0-vs-N1 |
2.158100E-02 |
| N0-vs-N2 |
9.581400E-01 |
| N1-vs-N2 |
3.902200E-01 |
|
|
